Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - TETRAPHASE PHARMACEUTICALS INC | ttph-ex322_11.htm |
| EX-32.1 - EX-32.1 - TETRAPHASE PHARMACEUTICALS INC | ttph-ex321_8.htm |
| EX-31.2 - EX-31.2 - TETRAPHASE PHARMACEUTICALS INC | ttph-ex312_9.htm |
| EX-31.1 - EX-31.1 - TETRAPHASE PHARMACEUTICALS INC | ttph-ex311_13.htm |
| EX-23.1 - EX-23.1 - TETRAPHASE PHARMACEUTICALS INC | ttph-ex231_6.htm |
| EX-10.31 - EX-10.31 - TETRAPHASE PHARMACEUTICALS INC | ttph-ex1031_87.htm |
| EX-10.28 - EX-10.28 - TETRAPHASE PHARMACEUTICALS INC | ttph-ex1028_50.htm |
| EX-10.22 - EX-10.22 - TETRAPHASE PHARMACEUTICALS INC | ttph-ex1022_16.htm |
| EX-10.13 - EX-10.13 - TETRAPHASE PHARMACEUTICALS INC | ttph-ex1013_17.htm |
| 10-K - 10-K - TETRAPHASE PHARMACEUTICALS INC | ttph-10k_20171231.htm |
Exhibit 21.1
SUBSIDIARIES OF THE REGISTRANT
|
Name |
|
Jurisdiction of Organization |
|
Percentage Ownership |
|
|
|
|
|
|
|
Tetraphase Pharma Securities, Inc. |
|
Massachusetts |
|
100% |
|
Tetraphase Pharmaceuticals (Bermuda) Ltd. |
|
Bermuda |
|
100% |
|
Tetraphase Ireland Limited |
|
Republic of Ireland |
|
* |
|
Tetraphase UK Limited |
|
United Kingdom |
|
* |
*100% owned by Tetraphase Pharmaceuticals (Bermuda) Ltd.